This briefing has been postponed due to a winter storm warning. The Endocrine Society and Society for Women's Health Research will announce a new date soon. Please contact email@example.com to be notified when the briefing is rescheduled.
Washington, DC--The Endocrine Society and Society for Women's Health Research (SWHR®) are co-sponsoring a Congressional briefing on February 17 that will focus on the importance of including female subjects in both preclinical and clinical biomedical research, which could potentially revolutionize medical research and scientific discovery.
Although biomedical research is the driver of scientific discovery and innovative medical treatment, it is well known that women and minorities still are not adequately represented in most research studies. To truly usher in medical treatments that are tailored to the patient, women and minorities must be reflected in the research studies used to approve new and novel medical treatments.
Scientific findings indicate that women have a much higher rate of adverse effects from approved medical products, and these adverse effects have resulted in some medications being pulled off the market. Scientists must ensure that preclinical research balances the inclusion of males and females and that research on human subjects includes representation from minority populations to appropriately determine how and for what populations the next wave of medical products work.
With limited budget dollars, it is imperative that federally funded research be structured to maximize the value of the investment. At the February 17 briefing, national leaders in women's health and medical research will discuss how to improve scientific understanding of differences between men and women and how these differences impact health.
What: Maximizing the Benefits of Biomedical Research: Why We Need to Balance the Study of Males and Females - A Tale of Mice and Men
Congressional briefing co-sponsored by the Endocrine Society and the Society for Women's Health Research (SWHR®)
Who: Phyllis Greenberger, MSW, President and CEO, Society for Women's Health Research
Teresa K. Woodruff, PhD, Thomas J. Watkins Memorial Professor of Obstetrics and Gynecology, Northwestern University & Past President of the Endocrine Society
Janine Clayton, MD, National Institutes of Health Associate Director for Research on Women's Health, Director, NIH Office of Research on Women's Health
Marsha B. Henderson, MCRP, Assistant Commissioner for Women's Health, U.S. Food and Drug Administration
Date: Tuesday, February 17, 2015, 12 - 1:30 p.m. (ET)
Where: 1537 Longworth House Office Building
Lunch will be available
Founded in 1916, the Endocrine Society is the world's oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, the Endocrine Society's membership consists of over 18,000 scientists, physicians, educators, nurses and students in 122 countries. Society members represent all basic, applied and clinical interests in endocrinology. The Endocrine Society is based in Washington, DC. To learn more about the Society and the field of endocrinology, visit our site at http://www.
The Society for Women's Health Research (SWHR®), is a national non-profit based in Washington D.C. that is widely recognized as the thought-leader in promoting research on biological differences in disease and is dedicated to transforming women's health through science, advocacy, and education. Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the variety of diseases and conditions that uniquely affect women. For more information, visit http://www.